title: Therapies for exacerbation of myasthenia gravis. The mechanism of action of intravenous high-dose immunoglobulin G.
authors.affiliation: Clinica Neurologica, Università di Torino, Italy.
authors.forename: B
authors.initials: B
authors.lastname: Ferrero
authors.forename: L
authors.initials: L
authors.lastname: Durelli
authors.forename: R
authors.initials: R
authors.lastname: Cavallo
authors.forename: A
authors.initials: A
authors.lastname: Dutto
authors.forename: G
authors.initials: G
authors.lastname: Aimo
authors.forename: F
authors.initials: F
authors.lastname: Pecchio
authors.forename: B
authors.initials: B
authors.lastname: Bergamasco
mesh_terms: D001323:Autoantibodies / Q000032:analysis; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage*; D007167:Immunotherapy; D009157:Myasthenia Gravis / Q000628:therapy*; D011978:Receptors, Nicotinic / Q000276:immunology
chemical_list: D001323:Autoantibodies; D016756:Immunoglobulins, Intravenous; D011978:Receptors, Nicotinic